These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 35393106)

  • 1. Functional Status After Transcatheter and Surgical Aortic Valve Replacement: 2-Year Analysis From the SURTAVI Trial.
    Tuttle MK; Kiaii B; Van Mieghem NM; Laham RJ; Deeb GM; Windecker S; Chetcuti S; Yakubov SJ; Chawla A; Hockmuth D; Teefy P; Li S; Reardon MJ
    JACC Cardiovasc Interv; 2022 Apr; 15(7):728-738. PubMed ID: 35393106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality of Life 5 Years Following Transfemoral TAVR or SAVR in Intermediate Risk Patients.
    Kleiman NS; Van Mieghem NM; Reardon MJ; Gada H; Mumtaz M; Olsen PS; Heiser J; Merhi W; Chetcuti S; Deeb GM; Chawla A; Kiaii B; Teefy P; Chu MWA; Yakubov SJ; Windecker S; Althouse AD; Baron SJ
    JACC Cardiovasc Interv; 2024 Apr; 17(8):979-988. PubMed ID: 38658126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of Outcomes After Transcatheter vs Surgical Aortic Valve Replacement Among Patients at Intermediate Operative Risk With a History of Coronary Artery Bypass Graft Surgery: A Post Hoc Analysis of the SURTAVI Randomized Clinical Trial.
    Reardon MJ; Heijmen RH; Van Mieghem NM; Williams MR; Yakubov SJ; Watson D; Kleiman NS; Conte J; Chawla A; Hockmuth D; Petrossian G; Robinson N; Kappetein AP; Li S; Popma JJ
    JAMA Cardiol; 2019 Aug; 4(8):810-814. PubMed ID: 31215985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Self-Expanding Transcatheter Aortic Valve Replacement in Patients With Low-Gradient Aortic Stenosis.
    Chetcuti SJ; Deeb GM; Popma JJ; Yakubov SJ; Grossman PM; Patel HJ; Casale A; Dauerman HL; Resar JR; Boulware MJ; Dries-Devlin JL; Li S; Oh JK; Reardon MJ
    JACC Cardiovasc Imaging; 2019 Jan; 12(1):67-80. PubMed ID: 30448116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Repositioning on Outcomes Following Transcatheter Aortic Valve Replacement With a Self-Expandable Valve.
    Attizzani GF; Dallan LAP; Markowitz A; Yakubov SJ; Deeb GM; Reardon MJ; Forrest JK; Mangi AA; Huang J; Popma JJ
    JACC Cardiovasc Interv; 2020 Aug; 13(15):1816-1824. PubMed ID: 32763073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 1-Year Results in Patients Undergoing Transcatheter Aortic Valve Replacement With Failed Surgical Bioprostheses.
    Deeb GM; Chetcuti SJ; Reardon MJ; Patel HJ; Grossman PM; Schreiber T; Forrest JK; Bajwa TK; O'Hair DP; Petrossian G; Robinson N; Katz S; Hartman A; Dauerman HL; Schmoker J; Khabbaz K; Watson DR; Yakubov SJ; Oh JK; Li S; Kleiman NS; Adams DH; Popma JJ
    JACC Cardiovasc Interv; 2017 May; 10(10):1034-1044. PubMed ID: 28521921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-Term Health Benefit of Transcatheter Aortic Valve Replacement in Patients With Chronic Lung Disease.
    Crestanello JA; Popma JJ; Adams DH; Deeb GM; Mumtaz M; George B; Huang J; Reardon MJ
    JACC Cardiovasc Interv; 2017 Nov; 10(22):2283-2293. PubMed ID: 29102579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health Status After Transcatheter or Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis at Increased Surgical Risk: Results From the CoreValve US Pivotal Trial.
    Arnold SV; Reynolds MR; Wang K; Magnuson EA; Baron SJ; Chinnakondepalli KM; Reardon MJ; Tadros PN; Zorn GL; Maini B; Mumtaz MA; Brown JM; Kipperman RM; Adams DH; Popma JJ; Cohen DJ;
    JACC Cardiovasc Interv; 2015 Aug; 8(9):1207-1217. PubMed ID: 26292584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of SAPIEN 3 Transcatheter Valve Implantation on Health Status in Patients With Severe Aortic Stenosis at Intermediate Surgical Risk: Results From the PARTNER S3i Trial.
    Baron SJ; Thourani VH; Kodali S; Arnold SV; Wang K; Magnuson EA; Pichard AD; Babaliaros V; George I; Miller DC; Tuzcu EM; Greason K; Herrmann HC; Smith CR; Leon MB; Cohen DJ;
    JACC Cardiovasc Interv; 2018 Jun; 11(12):1188-1198. PubMed ID: 29860075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complete 2-Year Results Confirm Bayesian Analysis of the SURTAVI Trial.
    Van Mieghem NM; Popma JJ; Deeb GM; Yakubov SJ; Serruys PW; Windecker S; Søndergaard L; Mumtaz M; Gada H; Chetcuti S; Kleiman NS; Kodali S; George I; Teefy P; Kiaii B; Oh JK; Kappetein AP; Chang Y; Mugglin AS; Reardon MJ;
    JACC Cardiovasc Interv; 2020 Feb; 13(3):323-331. PubMed ID: 32029248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic implications of baseline 6-min walk test performance in intermediate risk patients undergoing transcatheter aortic valve replacement.
    Sathananthan J; Green P; Finn M; Wood DA; Lauck S; Crowley A; Alu M; Arnold SV; Cohen D; Kapadia S; Mack M; Thourani VH; Kodali S; Leon M; Webb JG
    Catheter Cardiovasc Interv; 2021 Jan; 97(1):E154-E160. PubMed ID: 32521123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Computed Tomography-Based Indexed Aortic Annulus Size to Predict Prosthesis-Patient Mismatch.
    Head SJ; Reardon MJ; Deeb GM; Van Mieghem NM; Popma JJ; Gleason TG; Williams MR; Radhakrishnan S; Fremes S; Oh JK; Chang Y; Boulware MJ; Kappetein AP
    Circ Cardiovasc Interv; 2019 Apr; 12(4):e007396. PubMed ID: 30929507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health status after transcatheter aortic valve replacement in patients at extreme surgical risk: results from the CoreValve U.S. trial.
    Osnabrugge RL; Arnold SV; Reynolds MR; Magnuson EA; Wang K; Gaudiani VA; Stoler RC; Burdon TA; Kleiman N; Reardon MJ; Adams DH; Popma JJ; Cohen DJ;
    JACC Cardiovasc Interv; 2015 Feb; 8(2):315-323. PubMed ID: 25700755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Self-expanding Transcatheter vs Surgical Aortic Valve Replacement in Intermediate-Risk Patients: 5-Year Outcomes of the SURTAVI Randomized Clinical Trial.
    Van Mieghem NM; Deeb GM; Søndergaard L; Grube E; Windecker S; Gada H; Mumtaz M; Olsen PS; Heiser JC; Merhi W; Kleiman NS; Chetcuti SJ; Gleason TG; Lee JS; Cheng W; Makkar RR; Crestanello J; George B; George I; Kodali S; Yakubov SJ; Serruys PW; Lange R; Piazza N; Williams MR; Oh JK; Adams DH; Li S; Reardon MJ;
    JAMA Cardiol; 2022 Oct; 7(10):1000-1008. PubMed ID: 36001335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Durability and Clinical Outcomes of Transcatheter Aortic Valve Replacement for Failed Surgical Bioprostheses.
    Dauerman HL; Deeb GM; O'Hair DP; Waksman R; Yakubov SJ; Kleiman NS; Chetcuti SJ; Hermiller JB; Bajwa T; Khabbaz K; de Marchena E; Salerno T; Dries-Devlin JL; Li S; Popma JJ; Reardon MJ
    Circ Cardiovasc Interv; 2019 Oct; 12(10):e008155. PubMed ID: 31607151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and Efficacy of Self-Expanding TAVR in Patients With Aortoventricular Angulation.
    Popma JJ; Reardon MJ; Yakubov SJ; Hermiller JB; Harrison JK; Gleason TG; Conte JV; Deeb GM; Chetcuti S; Oh JK; Boulware MJ; Huang J; Adams DH;
    JACC Cardiovasc Imaging; 2016 Aug; 9(8):973-81. PubMed ID: 27491485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two-Year Outcomes in Patients With Severe Aortic Valve Stenosis Randomized to Transcatheter Versus Surgical Aortic Valve Replacement: The All-Comers Nordic Aortic Valve Intervention Randomized Clinical Trial.
    Søndergaard L; Steinbrüchel DA; Ihlemann N; Nissen H; Kjeldsen BJ; Petursson P; Ngo AT; Olsen NT; Chang Y; Franzen OW; Engstrøm T; Clemmensen P; Olsen PS; Thyregod HG
    Circ Cardiovasc Interv; 2016 Jun; 9(6):. PubMed ID: 27296202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgical or Transcatheter Aortic-Valve Replacement in Intermediate-Risk Patients.
    Reardon MJ; Van Mieghem NM; Popma JJ; Kleiman NS; Søndergaard L; Mumtaz M; Adams DH; Deeb GM; Maini B; Gada H; Chetcuti S; Gleason T; Heiser J; Lange R; Merhi W; Oh JK; Olsen PS; Piazza N; Williams M; Windecker S; Yakubov SJ; Grube E; Makkar R; Lee JS; Conte J; Vang E; Nguyen H; Chang Y; Mugglin AS; Serruys PW; Kappetein AP;
    N Engl J Med; 2017 Apr; 376(14):1321-1331. PubMed ID: 28304219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term Outcomes of Transcatheter Aortic Valve Replacement With the Lotus Valve vs CoreValve/EvolutR: A Secondary Analysis of the REPRISE III Randomized Clinical Trial.
    Rizik DG; Rajagopal V; Makkar RR; Bajwa T; Kleiman NS; Linke A; Kereiakes DJ; Waksman R; Thourani VH; Stoler RC; Mishkel GJ; Iyer VS; Buchbinder M; Götberg M; Bjursten H; Allocco DJ; Reardon MJ
    JAMA Netw Open; 2022 Oct; 5(10):e2238792. PubMed ID: 36301543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Echocardiographic Results of Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients: The PARTNER 3 Trial.
    Pibarot P; Salaun E; Dahou A; Avenatti E; Guzzetti E; Annabi MS; Toubal O; Bernier M; Beaudoin J; Ong G; Ternacle J; Krapf L; Thourani VH; Makkar R; Kodali SK; Russo M; Kapadia SR; Malaisrie SC; Cohen DJ; Leipsic J; Blanke P; Williams MR; McCabe JM; Brown DL; Babaliaros V; Goldman S; Szeto WY; Généreux P; Pershad A; Alu MC; Xu K; Rogers E; Webb JG; Smith CR; Mack MJ; Leon MB; Hahn RT;
    Circulation; 2020 May; 141(19):1527-1537. PubMed ID: 32272848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.